ArticleScientific reports2026
Higher psychological frailty index is associated with incident cardiometabolic diseases in Chinese adults aged 45 years and older.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To prospectively investigate the association between the Psychological Frailty Index (PFI) and incident cardiometabolic diseases in middle-aged and older adults. Data were obtained from the China Health and Retirement Longitudinal Study (CHARLS). A total of 4,060 participants aged ≥ 45 years who were free of diabetes, heart disease, and stroke at baseline were included. The PFI was constructed from 15 items covering psychological distress, cognitive orientation, subjective physical vulnerability, and memory function. Incident CMD was defined as the occurrence of diabetes, heart disease, or stroke during follow-up. Multivariable Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Restricted cubic spline analyses assessed dose-response relationships, and receiver operating characteristic analyses evaluated the incremental predictive value of PFI. During a median follow-up of 24 months, higher PFI was significantly associated with increased risk of incident CMD. In the fully adjusted model, each 0.1-point increase in PFI was associated with higher risks of CMD (HR = 1.16, 95% CI: 1.09-1.23), diabetes (HR = 1.13, 95% CI: 1.02-1.26), heart disease (HR = 1.14, 95% CI: 1.05-1.24), and stroke (HR = 1.43, 95% CI: 1.24-1.64). Participants in the highest PFI group had significantly greater risks of CMD and its components than those in the lowest group, with the strongest association observed for stroke. Spline analyses suggested a progressive increase in CMD risk across higher PFI levels. Adding PFI to traditional risk factors significantly improved discrimination for overall CMD and stroke, but not for diabetes or heart disease. Higher PFI was independently associated with incident CMD, particularly stroke, among middle-aged and older adults. PFI may serve as a complementary marker for cardiometabolic risk assessment, especially for identifying individuals at elevated risk of overall CMD and stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.